Up to 75 percent of medicines contain animal-sourced products. Paraveganio is the first medicinal product to carry The Vegan Society’s Vegan Trademark. The axunio-produced drug contains 500mg of paracetamol and can be used like the regular painkiller. It negates magnesium stearate, which is frequently of animal origin and found in most over-the-counter paracetamol products.
Paraveganio appears to be as effective as non-vegan certified paracetamol in treating mild fevers and moderate pain. In place of animal-derived magnesium stearate is a purely plant-sourced alternative.
The certification of its first vegan medicine represents a landmark moment for the Vegan Trademark. Already found on a wide variety of products, including food, beverages and beauty items, it has now branched into a highly lucrative and wide-reaching sector. Pharmaceuticals have long been a cause for concern for vegans, thanks to the prolific animal testing that has dogged the sector for decades. Until now, there have been few options for critically ill people who steer clear of all animal products.
We couldn’t be prouder to be bringing the world’s first vegan-certified drug to the market. Of course, to have it certified by The Vegan Society’s Vegan Trademark – the gold standard in vegan labelling – makes it that much more special too. Many people are surprised to hear that the majority of medications, including over-the-counter products such as paracetamol, contain animal derivatives or have been tested on animals. We know there’s a gap in the market for a vegan-certified paracetamol and are so delighted to be able to offer our product to consumers.
unknownx500
